Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 71 citing de Jongh: Free fatty acid levels modulate microvascular function. (0.07 sec) 

Vascular complications in diabetes mellitus: the role of endothelial dysfunction


C Schalkwijk, C Stehouwer - Clinical Science, 2005 - submit.clinsci.org
Abbreviations: AGE, advanced glycosylation end-product; Ang II, angiotensin II;
CRP, C-reactive protein; DAG, diacylglycerol; eNOS, endothelial NOS; ET-1,
endothelin-1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GlcNAc, N- ...
Cited by 119 - Related articles - Cached - BL Direct - All 12 versions

Cardiovascular actions of insulin

- endojournals.org
R Muniyappa, M Montagnani, KK Koh, MJ … - Endocrine reviews, 2007 - Endocrine Soc
Insulin has important vascular actions to stimulate production of nitric oxide
from endothelium. This leads to capillary recruitment, vasodilation, increased
blood flow, and subsequent augmentation of glucose disposal in classical ...
Cited by 99 - Related articles - BL Direct - All 5 versions

Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes

- shouxi.net
JB Meigs, CJ O'Donnell, GH Tofler, EJ … - Diabetes, 2006 - Am Diabetes Assoc
Endothelial dysfunction may precede development of type 2 diabetes. We tested
the hypothesis that elevated levels of hemostatic markers of endothelial
dysfunction, plasminogen activator inhibitor-1 (PAI-1) antigen, and von ...
Cited by 62 - Related articles - BL Direct - All 5 versions

Free fatty acids inhibit insulin signaling–stimulated endothelial nitric oxide synthase …

- diabetesjournals.org
XL Wang, L Zhang, K Youker, MX Zhang, J … - Diabetes, 2006 - Am Diabetes Assoc
In metabolic syndrome, a systemic deregulation of the insulin pathway leads to a
combined deregulation of insulin-regulated metabolism and cardiovascular
functions. Free fatty acids (FFAs), which are increased in metabolic ...
Cited by 48 - Related articles - BL Direct - All 4 versions

Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic …


H Bays, L Blonde, R Rosenson - Expert Review of Cardiovascular Therapy, 2006 - ingentaconnect.com
10.1586/14779072.4.6.871 © 2006 Future Drugs Ltd ISSN 1477-9072 871 ... Harold
Bays † , Lawrence Blonde and Robert Rosenson ... † Author for
correspondence L-MARC Research Center, Medical Director/President, 3288 ...
Cited by 36 - Related articles - All 4 versions

Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome


EH Serne, RT de Jongh, EC Eringa, RG … - Hypertension, 2007 - Am Heart Assoc
Obesity and a central body fat distribution, hypertension, insulin resistance,
glucose intolerance, dyslipidemia, and proinflammatory and prothrombotic factors
are all part of the metabolic syndrome. The metabolic syndrome defines a ...
Cited by 29 - Related articles - All 7 versions

Pathogenic potential of adipose tissue and metabolic consequences of adipocyte …


HE Bays, JM Gonzlez-Campoy, GA Bray, AE … - Expert Review of Cardiovascular Therapy, 2008 - ingentaconnect.com
When caloric intake exceeds caloric expenditure, the positive caloric balance
and storage of energy in adipose tissue often causes adipocyte hypertrophy and
visceral adipose tissue accumulation. These pathogenic anatomic ...
Cited by 26 - Related articles - All 4 versions

Adipose tissue fatty acid metabolism and cardiovascular disease


KN Frayn, BA Fielding, F Karpe - Current opinion in lipidology, 2005 - journals.lww.com
Purpose of review Fatty acid and triacylglycerol metabolism in adipose tissue
may be involved in the generation of risk factors for cardiovascular disease and
type 2 diabetes. Pharmaceutical companies are targeting adipocyte ...
Cited by 25 - Related articles - BL Direct - All 5 versions

Adiposopathy: why do adiposity and obesity cause metabolic disease?


H Bays, C Ballantyne - Future Lipidol., 2006 - Future Medicine
In the adipocentric paradigm, fat health affects patient health. Adiposopathy
('pathos' of adipose tissue or fat dysfunction) is more directly associated with
excessive fat-related metabolic disease (EFRMD) than adiposity (increased ...
Cited by 23 - Related articles - BL Direct - All 3 versions

FFAs: Do they play a role in vascular disease in the insulin resistance syndrome?


SS Shankar, HO Steinberg - Current Diabetes Reports, 2005 - Springer
Introduction The insulin resistance syndrome, otherwise known as syndrome X or
the metabolic syndrome, was first described by Reaven in 1988 [1]. The
importance of the insulin resistance syndrome is due to its independent ...
Cited by 18 - Related articles - All 2 versions


Result Page: 

1

2

3

4

5

6

7

8

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google